Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

44,493 stories, page 594 of 742

Advanced search

🌍Jul 6discoverynews.google.comTier 3 · Aggregated media

VERAXA Biotech AG Provides Pipeline and Partnering Update, Advances BiTAC Development Strategy

Quiver QuantitativeOriginal source

🌍Jul 6discoverynews.google.comTier 3 · Aggregated media

Can-Fite BioPharma Announces Completion of Enrollment of First 247 Patients in Pivotal Phase 3 Piclidenoson Psoriasis Study Ahead of Interim Analysis

Quiver QuantitativeOriginal source

🌍Jul 6discoverynews.google.comTier 3 · Aggregated media

Belite Bio Announces Tinlarebant Phase 3 DRAGON Study Results to Be Presented at ISCEV 2026 and ASRS 2026 Meetings

Quiver QuantitativeOriginal source

🌍Jul 6discoverynews.google.comTier 3 · Aggregated media

Opus Genetics Reaches FDA Alignment on Phase 3 Design for OPGx-LCA5; BLA May Be Submitted Based on 6-Month Data

Quiver QuantitativeOriginal source

🌍Jul 6discoverynews.google.comTier 3 · Aggregated media

Invivyd Announces Receipt of Twelve Months’ Advanced Notice of Emergency Use Authorization (EUA) Termination for PEMGARDA® and Provides an Update on Next Steps with the U.S. FDA

The Manila TimesOriginal source

🌍Jul 6discoverynews.google.comTier 3 · Aggregated media

Opus Genetics Announces FDA Alignment on Phase 3 Registrational Trial Design for OPGx-LCA5 in LCA5-Associated Inherited Retinal Disease

The Manila TimesOriginal source

🌍Jul 6discoverynews.google.comTier 3 · Aggregated media

Pharvaris Announces FDA Acceptance of New Drug Application for Deucrictibant IR for On-Demand Treatment of Hereditary Angioedema Attacks

The Manila TimesOriginal source

🌍Jul 6discoverynews.google.comTier 3 · Aggregated media

Can-Fite (NYSE American: CANF) reaches key Phase 3 psoriasis interim analysis milestone

Stock TitanOriginal source

🌍Jul 6discoverynews.google.comTier 3 · Aggregated media

PEMGARDA faces 2027 EUA end as Invivyd talks next steps with FDA

Stock TitanOriginal source

🌍Jul 6discoverynews.google.comTier 3 · Aggregated media

FDA accepts Pharvaris NDA for oral HAE attack treatment drug By Investing.com

Investing.com CanadaOriginal source

🌍Jul 6discoverynews.google.comTier 3 · Aggregated media

Ionis finishes key enrollment step for Angelman syndrome drug trial

Stock TitanOriginal source

🌍Jul 6discoverynews.google.comTier 3 · Aggregated media

Belite Bio takes Phase 3 Stargardt disease data to two eye meetings

Stock TitanOriginal source

🌍Jul 6discoverynews.google.comTier 3 · Aggregated media

Can-Fite’s psoriasis study reaches interim analysis after 247 patients enrolled

Stock TitanOriginal source

🌍Jul 6discoverynews.google.comTier 3 · Aggregated media

Opus Genetics clears FDA design for Phase 3 trial in childhood blindness

Stock TitanOriginal source

🌍Jul 6discoverynews.google.comTier 3 · Aggregated media

VERAXA says its BiTAC cancer pipeline is drawing partner interest

Stock TitanOriginal source

🌍Jul 6discoverynews.google.comTier 3 · Aggregated media

Can-Fite Achieves Key Pivotal Phase 3 Psoriasis Milestone with Completion of Patient Enrolment for the Interim Analysis: Data Expected Q4 2026/Q1 2027

Yahoo Finance SingaporeOriginal source

🌍Jul 6discoverynews.google.comTier 3 · Aggregated media

Ionis completes enrollment in pivotal cohort of the Phase 3 REVEAL study evaluating obudanersen in Angelman syndrome

Business WireOriginal source

🌍Jul 6discoverynews.google.comTier 3 · Aggregated media

Pharvaris Announces FDA Acceptance of NDA for Deucrictibant IR Capsule for On-Demand Treatment of HAE Attacks

Quiver QuantitativeOriginal source

🌍Jul 6discoverynews.google.comTier 3 · Aggregated media

Pharvaris wins FDA review for oral HAE attack treatment

Stock TitanOriginal source

🌍Jul 6discoverynews.google.comTier 3 · Aggregated media

Swiss drugmaker Novartis buys UK biotech firm in $1.5bn deal

The TimesOriginal source

🌍Jul 6discoverynews.google.comTier 3 · Aggregated media

Maharashtra FDA tightens milk safety rules

Dairy Business Middle East & AfricaOriginal source

🌍Jul 6discoverynews.google.comTier 3 · Aggregated media

Maharashtra FDA flags three beauty creams over toxic mercury and lead levels

DaijiworldOriginal source

🇺🇰Jul 6Regulatorygov.ukTier 1 · Regulatory source

NHS sets first-ever staff standards to tackle racism and violence

New NHS staff standards will make employers accountable for tackling racism, violence and sexual har...

UK Department of Health and Social CareOriginal source

🌍Jul 6discoverynews.google.comTier 3 · Aggregated media

AtaiBeckley Announces Last Patient Dosed in Phase 2b Elumina Trial of VLS-01 for Treatment-Resistant Depression; Topline Data Expected in Q4 2026

Quiver QuantitativeOriginal source

🌍Jul 6discoverynews.google.comTier 2 · Trade media

Novartis to acquire Myricx Bio in up to $1.5bn deal

Pharmaceutical TechnologyOriginal source

🌍Jul 6discoverynews.google.comTier 3 · Aggregated media

Immuron Advances IMM-529 (Clostridioides difficile infection) Partnering Strategy

The Manila TimesOriginal source

🌍Jul 6discoverynews.google.comTier 3 · Aggregated media

Should DayQuil be legal?

The ArgumentOriginal source

🌍Jul 6discoverynews.google.comTier 3 · Aggregated media

Reshoring Pharma and Biotech Manufacturing Ahead of This Summer’s Tariff Deadlines: Q&A with Ryan Last

Pharmaceutical ExecutiveOriginal source

🌍Jul 6discoverynews.google.comTier 3 · Aggregated media

Toxic Fairness Creams Linked to Kidney Disease in 18 Women

Deccan ChronicleOriginal source

🌍Jul 6discoverynews.google.comTier 3 · Aggregated media

Immuron seeks partner for gut infection drug IMM-529

Stock TitanOriginal source

🌍Jul 6discoverynews.google.comTier 3 · Aggregated media

A decade in deals: Houston biotech VC deals gradually increasing after ups and downs

The Business JournalsOriginal source

🌍Jul 6discoverynews.google.comTier 3 · Aggregated media

Alzheon to Present New Evidence of Neurovascular Protection and Preserved Brain Microstructure from Oral Valiltramiprosate Trials in APOE4/4 Alzheimer’s Patients at AAIC 2026 Conference in London

Business WireOriginal source

🌍Jul 6discoverynews.google.comTier 3 · Aggregated media

5 Biotech Stocks That Delivered 100% To 300% Gains: Did Your Winning Trades Offset Portfolio Losses?

RTTNewsOriginal source

🇺🇰Jul 6Regulatorygov.ukTier 1 · Regulatory source

Departmental minute on public dividend capital write-off: 2025 to 2026

DHSC minute on the cancellation and transfer of outstanding public dividend capital following the di...

UK Department of Health and Social CareOriginal source

🌍Jul 6Industryvaccineseurope.euTier 1 · Company source

Newsletter #20

Vaccines EuropeOriginal source

🌍Jul 6discoverynews.google.comTier 3 · Aggregated media

Germany Modifies Healthcare Reforms to Ease Burden on Pharma

Bloomberg.comOriginal source

🌍Jul 6discoverynews.google.comTier 3 · Aggregated media

Maharashtra FDA Mandates Free Potable Water in All Hotels and Restaurants

LatestLYOriginal source

🌍Jul 6discoverynews.google.comTier 2 · Trade media

Novartis to pay $1.1B upfront for Myricx to expand ADC pipeline

Fierce BiotechOriginal source

🌍Jul 6discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBIT forward of Edesa Biotech, Inc. – NASDAQ:EDSA

TradingViewOriginal source

🌍Jul 6discoverynews.google.comTier 3 · Aggregated media

How Evogene is changing the future for the pharma and agriculture markets

The Jerusalem PostOriginal source

🌍Jul 6discoverynews.google.comTier 3 · Aggregated media

Korea Pharma, Biotech Stocks Head for Event-Driven Second Half

bloomingbitOriginal source

🌍Jul 6discoverynews.google.comTier 2 · Trade media

I spoke to Anthropic’s CEO about how AI may affect biotech. Here’s what I learned

STATOriginal source

🌍Jul 6discoverynews.google.comTier 3 · Aggregated media

Zhejiang CONBA Pharmaceutical's Subsidiaries Sign Licensing Agreement With Adneuris

TradingViewOriginal source

🌍Jul 6discoverynews.google.comTier 3 · Aggregated media

Greater Bay Area emerges as launchpad for China's biotech rise

State Council Information OfficeOriginal source

🇺🇰Jul 6Regulatorygov.ukTier 1 · Regulatory source

NHS staff standards

The NHS staff standards set national minimum employment requirements to improve staff experience, ou...

UK Department of Health and Social CareOriginal source

🌍Jul 6discoverynews.google.comTier 3 · Aggregated media

Novartis buys UK ADC biotech Myricx Bio in up to $1.5bn deal

European Biotechnology MagazineOriginal source

🌍Jul 6discoverynews.google.comTier 3 · Aggregated media

Price to book forward of Beijing Beilu Pharmaceutical Co., Ltd. Class A – SZSE:300016

TradingViewOriginal source

🌍Jul 6discoverynews.google.comTier 3 · Aggregated media

Maharashtra FDA orders recall of Pak-origin Goree fairness creams, two others over toxic mercury, lead levels

Storyboard18Original source

🌍Jul 6discoverynews.google.comTier 3 · Aggregated media

Elevation Point Wealth Partners LLC Makes New $1.33 Million Investment in Teva Pharmaceutical Industries Ltd. $TEVA

MarketBeatOriginal source

🌍Jul 6discoverynews.google.comTier 3 · Aggregated media

Novartis to buy UK biotech Myricx Bio in $1.5bn deal

Financial TimesOriginal source

🌍Jul 6discoverynews.google.comTier 3 · Aggregated media

Celltrion Files Amendment for U.S. Phase 3 Trial of Keytruda Biosimilar CT-P51

Seoul Economic DailyOriginal source

🌍Jul 6discoverynews.google.comTier 3 · Aggregated media

48 Trillion Won Keytruda Biosimilar Race Heats Up

조선일보Original source

🌍Jul 6discoverynews.google.comTier 3 · Aggregated media

Algenomics CEO Sungwook Lee Invited as Speaker at RNA Symposium and Global Bio Conference

아시아경제Original source

🌍Jul 6discoverynews.google.comTier 3 · Aggregated media

AI Is Transforming Drug Discovery. Here Is the Next Trillion-Dollar Biotech Opportunity

AOL.comOriginal source

🌍Jul 6discoverynews.google.comTier 3 · Aggregated media

Cannabis Formula Granted "Breakthrough Therapy Designation" by FDA for Pain Treatment

azmarijuana.comOriginal source

🇩🇪Jul 6Mediadzne.deTier 2 · Direct publisher

Brain Scans and Beats at the Cologne Philharmonie

DZNE (Neurodegenerative Diseases)Original source

🌍Jul 6discoverynews.google.comTier 3 · Aggregated media

Travere Therapeutics Wins Much-Awaited Approval For Drug In Rare Kidney Disease

StocktwitsOriginal source

🌍Jul 6discoverynews.google.comTier 3 · Aggregated media

Nicox’s NCX 470 new drug application submitted in the United States by Kowa

Manufacturing ChemistOriginal source

🌍Jul 6discoverynews.google.comTier 3 · Aggregated media

The Geroscience Biomarker Gap: Why Immune Aging Endpoints Are About to Reshape Trial Design

The Clinical Trial VanguardOriginal source

🌍Jul 6discoverynews.google.comTier 3 · Aggregated media

Futura Medical: new US Eroxon deal and positive WSD4000 women's health data

Proactive financial newsOriginal source